[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Tablet and Capsule Budesonide Market, Global Outlook and Forecast 2022-2028

June 2024 | 70 pages | ID: T03F376E954FEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Tablets or capsules made of budesonide micropowder.

This report contains market size and forecasts of Tablet and Capsule Budesonide in global, including the following market information:

Global Tablet and Capsule Budesonide Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Tablet and Capsule Budesonide Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Tablet and Capsule Budesonide companies in 2021 (%)

The global Tablet and Capsule Budesonide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Tablet and Capsule Budesonide include AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation and Cipla, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tablet and Capsule Budesonide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Tablet and Capsule Budesonide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Tablet and Capsule Budesonide Market Segment Percentages, by Type, 2021 (%)
  • Tablet
  • Capsule
Global Tablet and Capsule Budesonide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Tablet and Capsule Budesonide Market Segment Percentages, by Application, 2021 (%)
  • Respiratory Disease Treatment
  • Nose Disease Treatment
  • Inflammatory Bowel Disease Treatment
  • Other
Global Tablet and Capsule Budesonide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Tablet and Capsule Budesonide Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Tablet and Capsule Budesonide revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Tablet and Capsule Budesonide revenues share in global market, 2021 (%)

Key companies Tablet and Capsule Budesonide sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Tablet and Capsule Budesonide sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • AstraZeneca
  • Teva
  • Mylan
  • Sandoz
  • Cosmo Pharmaceuticals
  • Salix
  • Chiesi Farmaceutici
  • Orion Corporation
  • Cipla
  • Synmosa Biopharma
  • Lunan Better Pharma
  • Shanghai Sine Promod
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Tablet and Capsule Budesonide Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Tablet and Capsule Budesonide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TABLET AND CAPSULE BUDESONIDE OVERALL MARKET SIZE

2.1 Global Tablet and Capsule Budesonide Market Size: 2021 VS 2028
2.2 Global Tablet and Capsule Budesonide Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Tablet and Capsule Budesonide Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Tablet and Capsule Budesonide Players in Global Market
3.2 Top Global Tablet and Capsule Budesonide Companies Ranked by Revenue
3.3 Global Tablet and Capsule Budesonide Revenue by Companies
3.4 Global Tablet and Capsule Budesonide Sales by Companies
3.5 Global Tablet and Capsule Budesonide Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Tablet and Capsule Budesonide Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Tablet and Capsule Budesonide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tablet and Capsule Budesonide Players in Global Market
  3.8.1 List of Global Tier 1 Tablet and Capsule Budesonide Companies
  3.8.2 List of Global Tier 2 and Tier 3 Tablet and Capsule Budesonide Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Tablet and Capsule Budesonide Market Size Markets, 2021 & 2028
  4.1.2 Tablet
  4.1.3 Capsule
4.2 By Type - Global Tablet and Capsule Budesonide Revenue & Forecasts
  4.2.1 By Type - Global Tablet and Capsule Budesonide Revenue, 2017-2022
  4.2.2 By Type - Global Tablet and Capsule Budesonide Revenue, 2023-2028
  4.2.3 By Type - Global Tablet and Capsule Budesonide Revenue Market Share, 2017-2028
4.3 By Type - Global Tablet and Capsule Budesonide Sales & Forecasts
  4.3.1 By Type - Global Tablet and Capsule Budesonide Sales, 2017-2022
  4.3.2 By Type - Global Tablet and Capsule Budesonide Sales, 2023-2028
  4.3.3 By Type - Global Tablet and Capsule Budesonide Sales Market Share, 2017-2028
4.4 By Type - Global Tablet and Capsule Budesonide Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Tablet and Capsule Budesonide Market Size, 2021 & 2028
  5.1.2 Respiratory Disease Treatment
  5.1.3 Nose Disease Treatment
  5.1.4 Inflammatory Bowel Disease Treatment
  5.1.5 Other
5.2 By Application - Global Tablet and Capsule Budesonide Revenue & Forecasts
  5.2.1 By Application - Global Tablet and Capsule Budesonide Revenue, 2017-2022
  5.2.2 By Application - Global Tablet and Capsule Budesonide Revenue, 2023-2028
  5.2.3 By Application - Global Tablet and Capsule Budesonide Revenue Market Share, 2017-2028
5.3 By Application - Global Tablet and Capsule Budesonide Sales & Forecasts
  5.3.1 By Application - Global Tablet and Capsule Budesonide Sales, 2017-2022
  5.3.2 By Application - Global Tablet and Capsule Budesonide Sales, 2023-2028
  5.3.3 By Application - Global Tablet and Capsule Budesonide Sales Market Share, 2017-2028
5.4 By Application - Global Tablet and Capsule Budesonide Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Tablet and Capsule Budesonide Market Size, 2021 & 2028
6.2 By Region - Global Tablet and Capsule Budesonide Revenue & Forecasts
  6.2.1 By Region - Global Tablet and Capsule Budesonide Revenue, 2017-2022
  6.2.2 By Region - Global Tablet and Capsule Budesonide Revenue, 2023-2028
  6.2.3 By Region - Global Tablet and Capsule Budesonide Revenue Market Share, 2017-2028
6.3 By Region - Global Tablet and Capsule Budesonide Sales & Forecasts
  6.3.1 By Region - Global Tablet and Capsule Budesonide Sales, 2017-2022
  6.3.2 By Region - Global Tablet and Capsule Budesonide Sales, 2023-2028
  6.3.3 By Region - Global Tablet and Capsule Budesonide Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Tablet and Capsule Budesonide Revenue, 2017-2028
  6.4.2 By Country - North America Tablet and Capsule Budesonide Sales, 2017-2028
  6.4.3 US Tablet and Capsule Budesonide Market Size, 2017-2028
  6.4.4 Canada Tablet and Capsule Budesonide Market Size, 2017-2028
  6.4.5 Mexico Tablet and Capsule Budesonide Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Tablet and Capsule Budesonide Revenue, 2017-2028
  6.5.2 By Country - Europe Tablet and Capsule Budesonide Sales, 2017-2028
  6.5.3 Germany Tablet and Capsule Budesonide Market Size, 2017-2028
  6.5.4 France Tablet and Capsule Budesonide Market Size, 2017-2028
  6.5.5 U.K. Tablet and Capsule Budesonide Market Size, 2017-2028
  6.5.6 Italy Tablet and Capsule Budesonide Market Size, 2017-2028
  6.5.7 Russia Tablet and Capsule Budesonide Market Size, 2017-2028
  6.5.8 Nordic Countries Tablet and Capsule Budesonide Market Size, 2017-2028
  6.5.9 Benelux Tablet and Capsule Budesonide Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Tablet and Capsule Budesonide Revenue, 2017-2028
  6.6.2 By Region - Asia Tablet and Capsule Budesonide Sales, 2017-2028
  6.6.3 China Tablet and Capsule Budesonide Market Size, 2017-2028
  6.6.4 Japan Tablet and Capsule Budesonide Market Size, 2017-2028
  6.6.5 South Korea Tablet and Capsule Budesonide Market Size, 2017-2028
  6.6.6 Southeast Asia Tablet and Capsule Budesonide Market Size, 2017-2028
  6.6.7 India Tablet and Capsule Budesonide Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Tablet and Capsule Budesonide Revenue, 2017-2028
  6.7.2 By Country - South America Tablet and Capsule Budesonide Sales, 2017-2028
  6.7.3 Brazil Tablet and Capsule Budesonide Market Size, 2017-2028
  6.7.4 Argentina Tablet and Capsule Budesonide Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Tablet and Capsule Budesonide Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Tablet and Capsule Budesonide Sales, 2017-2028
  6.8.3 Turkey Tablet and Capsule Budesonide Market Size, 2017-2028
  6.8.4 Israel Tablet and Capsule Budesonide Market Size, 2017-2028
  6.8.5 Saudi Arabia Tablet and Capsule Budesonide Market Size, 2017-2028
  6.8.6 UAE Tablet and Capsule Budesonide Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca Tablet and Capsule Budesonide Major Product Offerings
  7.1.4 AstraZeneca Tablet and Capsule Budesonide Sales and Revenue in Global (2017-2022)
  7.1.5 AstraZeneca Key News
7.2 Teva
  7.2.1 Teva Corporate Summary
  7.2.2 Teva Business Overview
  7.2.3 Teva Tablet and Capsule Budesonide Major Product Offerings
  7.2.4 Teva Tablet and Capsule Budesonide Sales and Revenue in Global (2017-2022)
  7.2.5 Teva Key News
7.3 Mylan
  7.3.1 Mylan Corporate Summary
  7.3.2 Mylan Business Overview
  7.3.3 Mylan Tablet and Capsule Budesonide Major Product Offerings
  7.3.4 Mylan Tablet and Capsule Budesonide Sales and Revenue in Global (2017-2022)
  7.3.5 Mylan Key News
7.4 Sandoz
  7.4.1 Sandoz Corporate Summary
  7.4.2 Sandoz Business Overview
  7.4.3 Sandoz Tablet and Capsule Budesonide Major Product Offerings
  7.4.4 Sandoz Tablet and Capsule Budesonide Sales and Revenue in Global (2017-2022)
  7.4.5 Sandoz Key News
7.5 Cosmo Pharmaceuticals
  7.5.1 Cosmo Pharmaceuticals Corporate Summary
  7.5.2 Cosmo Pharmaceuticals Business Overview
  7.5.3 Cosmo Pharmaceuticals Tablet and Capsule Budesonide Major Product Offerings
  7.5.4 Cosmo Pharmaceuticals Tablet and Capsule Budesonide Sales and Revenue in Global (2017-2022)
  7.5.5 Cosmo Pharmaceuticals Key News
7.6 Salix
  7.6.1 Salix Corporate Summary
  7.6.2 Salix Business Overview
  7.6.3 Salix Tablet and Capsule Budesonide Major Product Offerings
  7.6.4 Salix Tablet and Capsule Budesonide Sales and Revenue in Global (2017-2022)
  7.6.5 Salix Key News
7.7 Chiesi Farmaceutici
  7.7.1 Chiesi Farmaceutici Corporate Summary
  7.7.2 Chiesi Farmaceutici Business Overview
  7.7.3 Chiesi Farmaceutici Tablet and Capsule Budesonide Major Product Offerings
  7.7.4 Chiesi Farmaceutici Tablet and Capsule Budesonide Sales and Revenue in Global (2017-2022)
  7.7.5 Chiesi Farmaceutici Key News
7.8 Orion Corporation
  7.8.1 Orion Corporation Corporate Summary
  7.8.2 Orion Corporation Business Overview
  7.8.3 Orion Corporation Tablet and Capsule Budesonide Major Product Offerings
  7.8.4 Orion Corporation Tablet and Capsule Budesonide Sales and Revenue in Global (2017-2022)
  7.8.5 Orion Corporation Key News
7.9 Cipla
  7.9.1 Cipla Corporate Summary
  7.9.2 Cipla Business Overview
  7.9.3 Cipla Tablet and Capsule Budesonide Major Product Offerings
  7.9.4 Cipla Tablet and Capsule Budesonide Sales and Revenue in Global (2017-2022)
  7.9.5 Cipla Key News
7.10 Synmosa Biopharma
  7.10.1 Synmosa Biopharma Corporate Summary
  7.10.2 Synmosa Biopharma Business Overview
  7.10.3 Synmosa Biopharma Tablet and Capsule Budesonide Major Product Offerings
  7.10.4 Synmosa Biopharma Tablet and Capsule Budesonide Sales and Revenue in Global (2017-2022)
  7.10.5 Synmosa Biopharma Key News
7.11 Lunan Better Pharma
  7.11.1 Lunan Better Pharma Corporate Summary
  7.11.2 Lunan Better Pharma Tablet and Capsule Budesonide Business Overview
  7.11.3 Lunan Better Pharma Tablet and Capsule Budesonide Major Product Offerings
  7.11.4 Lunan Better Pharma Tablet and Capsule Budesonide Sales and Revenue in Global (2017-2022)
  7.11.5 Lunan Better Pharma Key News
7.12 Shanghai Sine Promod
  7.12.1 Shanghai Sine Promod Corporate Summary
  7.12.2 Shanghai Sine Promod Tablet and Capsule Budesonide Business Overview
  7.12.3 Shanghai Sine Promod Tablet and Capsule Budesonide Major Product Offerings
  7.12.4 Shanghai Sine Promod Tablet and Capsule Budesonide Sales and Revenue in Global (2017-2022)
  7.12.5 Shanghai Sine Promod Key News

8 GLOBAL TABLET AND CAPSULE BUDESONIDE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Tablet and Capsule Budesonide Production Capacity, 2017-2028
8.2 Tablet and Capsule Budesonide Production Capacity of Key Manufacturers in Global Market
8.3 Global Tablet and Capsule Budesonide Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 TABLET AND CAPSULE BUDESONIDE SUPPLY CHAIN ANALYSIS

10.1 Tablet and Capsule Budesonide Industry Value Chain
10.2 Tablet and Capsule Budesonide Upstream Market
10.3 Tablet and Capsule Budesonide Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Tablet and Capsule Budesonide Distributors and Sales Agents in Global

11 CONCLUSION


12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES

Table 1. Key Players of Tablet and Capsule Budesonide in Global Market
Table 2. Top Tablet and Capsule Budesonide Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Tablet and Capsule Budesonide Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Tablet and Capsule Budesonide Revenue Share by Companies, 2017-2022
Table 5. Global Tablet and Capsule Budesonide Sales by Companies, (K Units), 2017-2022
Table 6. Global Tablet and Capsule Budesonide Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Tablet and Capsule Budesonide Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Tablet and Capsule Budesonide Product Type
Table 9. List of Global Tier 1 Tablet and Capsule Budesonide Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tablet and Capsule Budesonide Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Tablet and Capsule Budesonide Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Tablet and Capsule Budesonide Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Tablet and Capsule Budesonide Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Tablet and Capsule Budesonide Sales (K Units), 2017-2022
Table 15. By Type - Global Tablet and Capsule Budesonide Sales (K Units), 2023-2028
Table 16. By Application – Global Tablet and Capsule Budesonide Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Tablet and Capsule Budesonide Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Tablet and Capsule Budesonide Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Tablet and Capsule Budesonide Sales (K Units), 2017-2022
Table 20. By Application - Global Tablet and Capsule Budesonide Sales (K Units), 2023-2028
Table 21. By Region – Global Tablet and Capsule Budesonide Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Tablet and Capsule Budesonide Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Tablet and Capsule Budesonide Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Tablet and Capsule Budesonide Sales (K Units), 2017-2022
Table 25. By Region - Global Tablet and Capsule Budesonide Sales (K Units), 2023-2028
Table 26. By Country - North America Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Tablet and Capsule Budesonide Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Tablet and Capsule Budesonide Sales, (K Units), 2017-2022
Table 29. By Country - North America Tablet and Capsule Budesonide Sales, (K Units), 2023-2028
Table 30. By Country - Europe Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Tablet and Capsule Budesonide Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Tablet and Capsule Budesonide Sales, (K Units), 2017-2022
Table 33. By Country - Europe Tablet and Capsule Budesonide Sales, (K Units), 2023-2028
Table 34. By Region - Asia Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Tablet and Capsule Budesonide Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Tablet and Capsule Budesonide Sales, (K Units), 2017-2022
Table 37. By Region - Asia Tablet and Capsule Budesonide Sales, (K Units), 2023-2028
Table 38. By Country - South America Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Tablet and Capsule Budesonide Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Tablet and Capsule Budesonide Sales, (K Units), 2017-2022
Table 41. By Country - South America Tablet and Capsule Budesonide Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Tablet and Capsule Budesonide Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Tablet and Capsule Budesonide Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Tablet and Capsule Budesonide Sales, (K Units), 2023-2028
Table 46. AstraZeneca Corporate Summary
Table 47. AstraZeneca Tablet and Capsule Budesonide Product Offerings
Table 48. AstraZeneca Tablet and Capsule Budesonide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Teva Corporate Summary
Table 50. Teva Tablet and Capsule Budesonide Product Offerings
Table 51. Teva Tablet and Capsule Budesonide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Mylan Corporate Summary
Table 53. Mylan Tablet and Capsule Budesonide Product Offerings
Table 54. Mylan Tablet and Capsule Budesonide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Sandoz Corporate Summary
Table 56. Sandoz Tablet and Capsule Budesonide Product Offerings
Table 57. Sandoz Tablet and Capsule Budesonide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Cosmo Pharmaceuticals Corporate Summary
Table 59. Cosmo Pharmaceuticals Tablet and Capsule Budesonide Product Offerings
Table 60. Cosmo Pharmaceuticals Tablet and Capsule Budesonide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Salix Corporate Summary
Table 62. Salix Tablet and Capsule Budesonide Product Offerings
Table 63. Salix Tablet and Capsule Budesonide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Chiesi Farmaceutici Corporate Summary
Table 65. Chiesi Farmaceutici Tablet and Capsule Budesonide Product Offerings
Table 66. Chiesi Farmaceutici Tablet and Capsule Budesonide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Orion Corporation Corporate Summary
Table 68. Orion Corporation Tablet and Capsule Budesonide Product Offerings
Table 69. Orion Corporation Tablet and Capsule Budesonide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Cipla Corporate Summary
Table 71. Cipla Tablet and Capsule Budesonide Product Offerings
Table 72. Cipla Tablet and Capsule Budesonide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Synmosa Biopharma Corporate Summary
Table 74. Synmosa Biopharma Tablet and Capsule Budesonide Product Offerings
Table 75. Synmosa Biopharma Tablet and Capsule Budesonide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Lunan Better Pharma Corporate Summary
Table 77. Lunan Better Pharma Tablet and Capsule Budesonide Product Offerings
Table 78. Lunan Better Pharma Tablet and Capsule Budesonide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Shanghai Sine Promod Corporate Summary
Table 80. Shanghai Sine Promod Tablet and Capsule Budesonide Product Offerings
Table 81. Shanghai Sine Promod Tablet and Capsule Budesonide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Tablet and Capsule Budesonide Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global Tablet and Capsule Budesonide Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Tablet and Capsule Budesonide Production by Region, 2017-2022 (K Units)
Table 85. Global Tablet and Capsule Budesonide Production by Region, 2023-2028 (K Units)
Table 86. Tablet and Capsule Budesonide Market Opportunities & Trends in Global Market
Table 87. Tablet and Capsule Budesonide Market Drivers in Global Market
Table 88. Tablet and Capsule Budesonide Market Restraints in Global Market
Table 89. Tablet and Capsule Budesonide Raw Materials
Table 90. Tablet and Capsule Budesonide Raw Materials Suppliers in Global Market
Table 91. Typical Tablet and Capsule Budesonide Downstream
Table 92. Tablet and Capsule Budesonide Downstream Clients in Global Market
Table 93. Tablet and Capsule Budesonide Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Tablet and Capsule Budesonide Segment by Type
Figure 2. Tablet and Capsule Budesonide Segment by Application
Figure 3. Global Tablet and Capsule Budesonide Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Tablet and Capsule Budesonide Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Tablet and Capsule Budesonide Revenue, 2017-2028 (US$, Mn)
Figure 7. Tablet and Capsule Budesonide Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Tablet and Capsule Budesonide Revenue in 2021
Figure 9. By Type - Global Tablet and Capsule Budesonide Sales Market Share, 2017-2028
Figure 10. By Type - Global Tablet and Capsule Budesonide Revenue Market Share, 2017-2028
Figure 11. By Type - Global Tablet and Capsule Budesonide Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Tablet and Capsule Budesonide Sales Market Share, 2017-2028
Figure 13. By Application - Global Tablet and Capsule Budesonide Revenue Market Share, 2017-2028
Figure 14. By Application - Global Tablet and Capsule Budesonide Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Tablet and Capsule Budesonide Sales Market Share, 2017-2028
Figure 16. By Region - Global Tablet and Capsule Budesonide Revenue Market Share, 2017-2028
Figure 17. By Country - North America Tablet and Capsule Budesonide Revenue Market Share, 2017-2028
Figure 18. By Country - North America Tablet and Capsule Budesonide Sales Market Share, 2017-2028
Figure 19. US Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Tablet and Capsule Budesonide Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Tablet and Capsule Budesonide Sales Market Share, 2017-2028
Figure 24. Germany Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 25. France Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Tablet and Capsule Budesonide Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Tablet and Capsule Budesonide Sales Market Share, 2017-2028
Figure 33. China Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 37. India Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Tablet and Capsule Budesonide Revenue Market Share, 2017-2028
Figure 39. By Country - South America Tablet and Capsule Budesonide Sales Market Share, 2017-2028
Figure 40. Brazil Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Tablet and Capsule Budesonide Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Tablet and Capsule Budesonide Sales Market Share, 2017-2028
Figure 44. Turkey Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Tablet and Capsule Budesonide Revenue, (US$, Mn), 2017-2028
Figure 48. Global Tablet and Capsule Budesonide Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Tablet and Capsule Budesonide by Region, 2021 VS 2028
Figure 50. Tablet and Capsule Budesonide Industry Value Chain
Figure 51. Marketing Channels


More Publications